cerrar
Tagged with Switzerland,

Interview: Georg Boonen – CEO, Max Zeller, Switzerland
The CEO of Max Zeller, a Swiss Phytopharmaceutical company, highlights the immense benefits his products have and furthermore discusses the…

Shigeo Taniuchi – Head of EMEA, Santen, Switzerland
Santen’s Head of EMEA explains why the company established their new regional headquarters in Geneva, Switzerland and highlights the three key…

Interview: Benoit Dubuis – Chairman, Campus Biotech,…
How would you present the strengths of the Lake Geneva region’s strengths to our international audience? The Lake Geneva region, which we often…

Interview: Urs Suter – CEO (Jan 2000 – Dec 2016),…
The CEO of Siemens’ Healthineers Switzerland explains the reasons behind the spinoff of the former Siemens AG segment and elaborates how the…

Interview: Sandrine Deprost-Catelin – General Manager,…
The general manager of ResMed’s Swiss affiliate explains the company’s efforts to raise the awareness of sleep apnea in the country, and…

Interview: Nasri Nahas – CEO, Biopôle, Switzerland
Nasri Nahas, CEO of Biopôle in Switzerland, discusses his motivations for joining the biotech, and his mission to re-position the organization as a…

Gilles Pluntz – Chairman of the Group Operating Committee…
The Chairman of Ferring’s Group Operating Committee and Senior Vice President Europe-Canada elaborates on how Europe can be the thinking engine for…

Interview: Giovan Maria Zanini – Board member, Swissmedic…
An expert in the implementation of Swiss federal laws within Switzerland’s constituent cantons, Giovan Maria Zanini discusses the evolution of Swiss…

Interview: Dr. Ignazio Cassis – President, curafutura…
Switzerland may have a world class healthcare system, but small adjustments are needed to ensure incentives for payer and providers are properly…

Interview: Thomas Früh – CEO, Bachem, Switzerland
Advances in delivery technology and manufacturing costs have driven a surge of activity in peptide drug development, says Thomas Früh, CEO of Bachem…

Interview: Daniel Pedrett – CEO, Rohner Chem, Switzerland
Outsourcing of API synthesis has stabilized in the decade since Rohner Chem entered the pharma sector in earnest, and according to CEO Daniel Pedrett…

Riccardo Braglia – Helsinn Group Vice Chairman and CEO,…
Helsinn is a leader in cancer supportive care, and Vice Chairman and CEO Riccardo Braglia enthusiastically discusses the Group’s entrance into the…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here